EU Regulator Backs Use Of Novavax Covid Shot As A Booster
NDTV
The vaccine, Nuvaxovid, is designed to target the strain of the virus that originally emerged in China. The EMA's recommendation is for people who previously were inoculated with either the Novavax shot, or any other COVID vaccine.
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
The vaccine, Nuvaxovid, is designed to target the strain of the virus that originally emerged in China. The EMA's recommendation is for people who previously were inoculated with either the Novavax shot, or any other COVID vaccine.
Separately on Thursday, the EMA backed two separate COVID-19 vaccine boosters updated to target the Omicron variant of the virus.
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.
